Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.44 - $1.22 $13,819 - $38,317
31,408 New
31,408 $21,000
Q2 2021

Aug 16, 2021

SELL
$12.89 - $16.58 $453,263 - $583,019
-35,164 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$14.0 - $20.72 $1.12 Million - $1.66 Million
-80,341 Reduced 69.56%
35,164 $505,000
Q4 2020

Feb 16, 2021

BUY
$12.67 - $26.23 $1.17 Million - $2.41 Million
91,996 Added 391.32%
115,505 $2.27 Million
Q3 2020

Nov 13, 2020

BUY
$11.92 - $15.87 $280,227 - $373,087
23,509 New
23,509 $305,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.08B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.